NEU 1.25% $20.25 neuren pharmaceuticals limited

FDA, page-3

  1. 929 Posts.
    lightbulb Created with Sketch. 154
    A contrarian view and one not outside the realms of possibility, is that big players knew in advance of the drugs pending approval and sold down shares on the news to scare the retail market into offloading so they could pick up at a significant discount. That's the conspiracy theorist in me purely surmising

    https://www.biopharmadive.com/news/billy-dunn-fda-depart-agency-neuroscience-alzheimers/643627/

    https://hotcopper.com.au/data/attachments/5109/5109091-585681c4f959dde7c97c3c9a3dfd37cd.jpg



    Last edited by Saus: 08/03/23
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.